These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
537 related articles for article (PubMed ID: 22070571)
1. Controlled intracellular release of doxorubicin in multidrug-resistant cancer cells by tuning the shell-pore sizes of mesoporous silica nanoparticles. Gao Y; Chen Y; Ji X; He X; Yin Q; Zhang Z; Shi J; Li Y ACS Nano; 2011 Dec; 5(12):9788-98. PubMed ID: 22070571 [TBL] [Abstract][Full Text] [Related]
2. Hybrid lipid-capped mesoporous silica for stimuli-responsive drug release and overcoming multidrug resistance. Han N; Zhao Q; Wan L; Wang Y; Gao Y; Wang P; Wang Z; Zhang J; Jiang T; Wang S ACS Appl Mater Interfaces; 2015 Feb; 7(5):3342-51. PubMed ID: 25584634 [TBL] [Abstract][Full Text] [Related]
3. Mesoporous silica nanoparticles loading doxorubicin reverse multidrug resistance: performance and mechanism. Shen J; He Q; Gao Y; Shi J; Li Y Nanoscale; 2011 Oct; 3(10):4314-22. PubMed ID: 21892492 [TBL] [Abstract][Full Text] [Related]
4. A pH-responsive mesoporous silica nanoparticles-based multi-drug delivery system for overcoming multi-drug resistance. He Q; Gao Y; Zhang L; Zhang Z; Gao F; Ji X; Li Y; Shi J Biomaterials; 2011 Oct; 32(30):7711-20. PubMed ID: 21816467 [TBL] [Abstract][Full Text] [Related]
5. Doxorubicin-tethered responsive gold nanoparticles facilitate intracellular drug delivery for overcoming multidrug resistance in cancer cells. Wang F; Wang YC; Dou S; Xiong MH; Sun TM; Wang J ACS Nano; 2011 May; 5(5):3679-92. PubMed ID: 21462992 [TBL] [Abstract][Full Text] [Related]
6. Redox-responsive nanoparticles from the single disulfide bond-bridged block copolymer as drug carriers for overcoming multidrug resistance in cancer cells. Wang YC; Wang F; Sun TM; Wang J Bioconjug Chem; 2011 Oct; 22(10):1939-45. PubMed ID: 21866903 [TBL] [Abstract][Full Text] [Related]
7. Enzyme-induced and tumor-targeted drug delivery system based on multifunctional mesoporous silica nanoparticles. Cheng YJ; Luo GF; Zhu JY; Xu XD; Zeng X; Cheng DB; Li YM; Wu Y; Zhang XZ; Zhuo RX; He F ACS Appl Mater Interfaces; 2015 May; 7(17):9078-87. PubMed ID: 25893819 [TBL] [Abstract][Full Text] [Related]
8. Cell-specific intracellular anticancer drug delivery from mesoporous silica nanoparticles with pH sensitivity. Luo Z; Cai K; Hu Y; Zhang B; Xu D Adv Healthc Mater; 2012 May; 1(3):321-5. PubMed ID: 23184747 [TBL] [Abstract][Full Text] [Related]
9. Co-delivery of doxorubicin and RNA using pH-sensitive poly (β-amino ester) nanoparticles for reversal of multidrug resistance of breast cancer. Tang S; Yin Q; Zhang Z; Gu W; Chen L; Yu H; Huang Y; Chen X; Xu M; Li Y Biomaterials; 2014 Jul; 35(23):6047-59. PubMed ID: 24797883 [TBL] [Abstract][Full Text] [Related]
10. Polydopamine coated hollow mesoporous silica nanoparticles as pH-sensitive nanocarriers for overcoming multidrug resistance. Shao M; Chang C; Liu Z; Chen K; Zhou Y; Zheng G; Huang Z; Xu H; Xu P; Lu B Colloids Surf B Biointerfaces; 2019 Nov; 183():110427. PubMed ID: 31408782 [TBL] [Abstract][Full Text] [Related]
11. Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318. Chen LM; Liang YJ; Ruan JW; Ding Y; Wang XW; Shi Z; Gu LQ; Yang XP; Fu LW J Pharm Pharmacol; 2004 Aug; 56(8):1061-6. PubMed ID: 15285852 [TBL] [Abstract][Full Text] [Related]
12. TPGS functionalized mesoporous silica nanoparticles for anticancer drug delivery to overcome multidrug resistance. Zhao P; Li L; Zhou S; Qiu L; Qian Z; Liu X; Cao X; Zhang H Mater Sci Eng C Mater Biol Appl; 2018 Mar; 84():108-117. PubMed ID: 29519418 [TBL] [Abstract][Full Text] [Related]
13. A facile route for rapid synthesis of hollow mesoporous silica nanoparticles as pH-responsive delivery carrier. Xu H; Zhang H; Wang D; Wu L; Liu X; Jiao Z J Colloid Interface Sci; 2015 Aug; 451():101-7. PubMed ID: 25890118 [TBL] [Abstract][Full Text] [Related]
14. Hyaluronic acid modified mesoporous silica nanoparticles for targeted drug delivery to CD44-overexpressing cancer cells. Yu M; Jambhrunkar S; Thorn P; Chen J; Gu W; Yu C Nanoscale; 2013 Jan; 5(1):178-83. PubMed ID: 23076766 [TBL] [Abstract][Full Text] [Related]
15. Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7/DOX) cells. Wang TX; Yang XH Yao Xue Xue Bao; 2008 May; 43(5):461-6. PubMed ID: 18717331 [TBL] [Abstract][Full Text] [Related]
16. Enhanced effect of pH-sensitive mixed copolymer micelles for overcoming multidrug resistance of doxorubicin. Qiu L; Qiao M; Chen Q; Tian C; Long M; Wang M; Li Z; Hu W; Li G; Cheng L; Cheng L; Hu H; Zhao X; Chen D Biomaterials; 2014 Dec; 35(37):9877-9887. PubMed ID: 25201738 [TBL] [Abstract][Full Text] [Related]
17. Overcoming multidrug resistance with mesoporous silica nanorods as nanocarrier of doxorubicin. Li L; Huang X; Liu T; Liu H; Hao N; Chen D; Zhang Y; Li L; Tang F J Nanosci Nanotechnol; 2012 Jun; 12(6):4458-66. PubMed ID: 22905485 [TBL] [Abstract][Full Text] [Related]
18. Integrated hollow mesoporous silica nanoparticles for target drug/siRNA co-delivery. Ma X; Zhao Y; Ng KW; Zhao Y Chemistry; 2013 Nov; 19(46):15593-603. PubMed ID: 24123533 [TBL] [Abstract][Full Text] [Related]
19. pH-Dependent doxorubicin release from terpolymer of starch, polymethacrylic acid and polysorbate 80 nanoparticles for overcoming multi-drug resistance in human breast cancer cells. Shalviri A; Raval G; Prasad P; Chan C; Liu Q; Heerklotz H; Rauth AM; Wu XY Eur J Pharm Biopharm; 2012 Nov; 82(3):587-97. PubMed ID: 22995704 [TBL] [Abstract][Full Text] [Related]
20. Smart pH-sensitive and temporal-controlled polymeric micelles for effective combination therapy of doxorubicin and disulfiram. Duan X; Xiao J; Yin Q; Zhang Z; Yu H; Mao S; Li Y ACS Nano; 2013 Jul; 7(7):5858-69. PubMed ID: 23734880 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]